Analyst Price Target is $5.50
▲ +729.94% Upside Potential
This price target is based on 5 analysts offering 12 month price targets for Skylight Health Group in the last 3 months. The average price target is $5.50, with a high forecast of $0.00 and a low forecast of $0.00. The average price target represents a 729.94% upside from the last price of $0.66.
Current Consensus is
The current consensus among 5 investment analysts is to buy stock in Skylight Health Group.
Skylight Health Group Inc. operates as a healthcare services and technology company in the United States, Canada, the United Kingdom, and Colombia. It operates the US multi-state primary care health network, which provides a range of services from primary care, sub-specialty, allied health, and laboratory/diagnostic testing. The company also owns and operates a proprietary electronic health record system that supports the delivery of care to patients through telemedicine and other remote monitoring system integrations. In addition, it offers a disruptive subscription-based telemedicine service for the un/under-insured population. The company was formerly known as CB2 Insights Inc. and changed its name to Skylight Health Group Inc. in November 2020. Skylight Health Group Inc. was founded in 2014 and is headquartered in Mississauga, Canada.